Asarina Pharma AB (publ)

OM:ASAP Stock Report

Market Cap: SEK 634.0k

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Asarina Pharma Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Peter Nordkild

Chief executive officer

SEK 2.7m

Total compensation

CEO salary percentage73.2%
CEO tenure8.8yrs
CEO ownership1.2%
Management average tenureno data
Board average tenure6.8yrs

Recent management updates

Recent updates

Companies Like Asarina Pharma (STO:ASAP) Could Be Quite Risky

Jun 09
Companies Like Asarina Pharma (STO:ASAP) Could Be Quite Risky

CEO Compensation Analysis

How has Peter Nordkild's remuneration changed compared to Asarina Pharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023SEK 3mSEK 2m

-SEK 13m

Sep 30 2023n/an/a

-SEK 14m

Jun 30 2023n/an/a

-SEK 15m

Mar 31 2023n/an/a

-SEK 14m

Dec 31 2022SEK 2mSEK 2m

-SEK 13m

Sep 30 2022n/an/a

-SEK 12m

Jun 30 2022n/an/a

-SEK 17m

Mar 31 2022n/an/a

-SEK 29m

Dec 31 2021SEK 3mSEK 2m

-SEK 32m

Sep 30 2021n/an/a

-SEK 49m

Jun 30 2021n/an/a

-SEK 59m

Mar 31 2021n/an/a

-SEK 63m

Dec 31 2020SEK 3mSEK 3m

-SEK 75m

Sep 30 2020n/an/a

-SEK 72m

Jun 30 2020n/an/a

-SEK 75m

Mar 31 2020n/an/a

-SEK 80m

Dec 31 2019SEK 3mSEK 3m

-SEK 71m

Sep 30 2019n/an/a

-SEK 69m

Jun 30 2019n/an/a

-SEK 65m

Mar 31 2019n/an/a

-SEK 48m

Dec 31 2018SEK 3mSEK 3m

-SEK 44m

Compensation vs Market: Peter's total compensation ($USD262.15K) is about average for companies of similar size in the Swedish market ($USD253.61K).

Compensation vs Earnings: Peter's compensation has increased whilst the company is unprofitable.

CEO

Peter Nordkild (69 yo)

8.8yrs

Tenure

SEK 2,690,000

Compensation

Mr. Peter Nordkild, M.D. is Chief Executive Officer of Adenium Biotech ApS. Mr. Nordkild serves as Chief Executive Officer of ARTS Biologics. He is Chief Medical Officer at Asarina Pharma AB (publ) (former...

Board Members

NamePositionTenureCompensationOwnership
Torbjörn Bäckström
Chairman of Scientific Advisory Boardno datano data1.61%
SEK 10.2k
Paul de Potocki
Independent Chairman6.8yrsSEK 510.00kno data
Erin Gainer
Independent Director4.8yrsSEK 205.00kno data
Marianne Kock
Independent Director6.8yrsSEK 205.00kno data
Marie Bixo
Member of Scientific Advisory Boardno datano datano data
Marco Bortolato
Member of Scientific Advisory Boardno datano datano data
C. Epperson
Member of Scientific Advisory Boardno datano datano data

6.8yrs

Average Tenure

65.5yo

Average Age

Experienced Board: ASAP's board of directors are considered experienced (6.8 years average tenure).